The Biden administration’s drug policy strategy and lessons from Portugal
Past Event
On April 1, the Biden administration released its strategic drug policy plan, amid an intensifying drug epidemic with escalating overdose deaths across the United States. The policy guidance embraces many elements advocated by the drug reform policy community, such as enhancing evidence-based harm reduction efforts and expanding access to treatment. Among the global community, Portugal has been a leader in implementing many of these priorities with positive results, and is widely considered a model of drug policy reform.
On April 27, Foreign Policy at Brookings and the Embassy of Portugal hosted a webinar on drug policy reform, trends in the United States and around the world, and lessons from Portugal. After opening remarks by Domingos Fezas Vital, ambassador of Portugal to the United States, Senior Fellow Vanda Felbab-Brown moderated a panel discussion.
After their remarks, panelist took questions from the audience. Viewers submitted questions via email to events@brookings.edu or Twitter using #DrugPolicy.
Agenda
Introductory remarks
Vanda Felbab-Brown
Director - Initiative on Nonstate Armed Actors
Co-Director - Africa Security Initiative
Senior Fellow - Foreign Policy, Strobe Talbott Center for Security, Strategy, and Technology
Panelists
João Castel-Branco Goulão
National Coordinator for Drugs and Drug Addiction - Ministry of Health, Portugal
Keith Humphreys
Esther Ting Memorial Professor and Professor of Psychiatry - Stanford University
Vanda Felbab-Brown
Director - Initiative on Nonstate Armed Actors
Co-Director - Africa Security Initiative
Senior Fellow - Foreign Policy, Strobe Talbott Center for Security, Strategy, and Technology
More Information
To subscribe or manage your subscriptions to our top event topic lists, please visit our event topics page.
More
On February 24, Vanda Felbab-Brown joined the National Committee on US-China Relations for a discussion on “The faces of fentanyl: China, the United States, and those in-between.”
